Nano-materials developer Nanoco saw its shares dive on Wednesday despite forecasting a significant increase in revenue for the year ended 31 July.
University intellectual property commercialisation specialist Frontier IP announced on Wednesday that its portfolio company The Vaccine Group (TVG) has been awarded a £50,000 grant from the global Bacterial Vaccine Network, to support development of a vaccine to combat one of the main causes of bovine mastitis, E. coli.
Internet of things investment company Tern noted an announcement from its portfolio company FundamentalVR on Wednesday, that it has launched ‘Fundamental Surgery’, a “first-of-its-kind” software-as-a-service platform, in the US.
Chemistry digitising company DeepMatter has now entered into agreements with a total of five organisations for its ‘DigitalGlassware’ pioneer programme, which represents the minimum that it planned to initiate during 2018, it announced on Wednesday.
Transatlantic healthcare IP commercialisation group NetScientific announced on Wednesday that portfolio company Wanda, which it said uses machine learning to help healthcare providers better manage the risk and care of patients, has launched its new digital health application ‘Wanda CareLink’.
Advanced materials engineering group Versarien on Wednesday saw a second Department for International Trade (DIT) secondee join its ranks.
Akers Biosciences' losses burgeoned as second-quarter revenues were cut in half after softer sales of its flagship Heparin rapid assay products had offset a stronger showing in its breathalyser unit.
Medical imaging technology firm Feedback’s operating company Feedback Medical on Wednesday received its first order via GE Healthcare for its patented image texture analysis technology TexRAD.
British independent oil and gas company Savannah Petroleum on Wednesday made a new oil discovery through its Eridal-1 exploration well in the Agadem Rift Basin, South East Niger.
Cadence Minerals on Wednesday reported that investee company Auroch Minerals accelerated its drilling programme with the start of works at its Bonaventura base metals project in South Australia.
AIM-listed Stilo International reported a fall in first-half profits after the software group was unable to retain a key customer.
Precious metals exploration and development company ECR Minerals updated the market on Wednesday, following the visit by the company to Argentina to discuss the status and plans in respect of its existing interests, and also to consider potential new opportunities in Argentina that may complement existing interests.
Africa focused energy company Kibo Energy has signed a memorandum of understanding (MoU) for the acquisition of a 60% equity interest in Mast Energy Developments (MED) - a private UK-registered company targeting the development and operation of flexible power plants to service the reserve power generation market - it announced on Wednesday.
Virtual reality music content producer EVR Holdings announced an exclusive multi-year partnership with Alexandra Palace Trading on Wednesday.
Mineral resource company Keras Resources announced a number of appointments to advance the 10,000 tonne bulk sampling metallurgical testwork programme at the Nayega Manganese Project in northern Togo on Wednesday, which it said hosted a current JORC Code mineral resource of 13. 97Mt at 12. 4% manganese.
Mining company Vast Resources announced the acquisition of an indirect 29. 41% interest in the Blueberry Project, which hosts highly prospective polymetallic mineralisation and is located in the ‘Golden Quadrilateral’ of Western Romania, on Wednesday.
Arena Events Group is looking to raise as much as £20m by way of a placing of up to 33. 33m new shares at a price of 60p as it agreed the acquisitions of Stuart Rental and TGP to boost its overseas operations.
AIM-listed copper ores company KEFI Minerals has appointed itself a new head of project implementation as the company ramps-up preparations for the development of its Tulu Kapi gold project in Ethiopia.
Clinical-stage biopharmaceutical company Motif Bio announced on Tuesday that the US Food and Drug Administration has accepted for filing its new drug application (NDA) for iclaprim - a targeted, gram-positive investigational antibiotic, for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
AIM-listed biotechnology company SalvaRx has entered into a conditional sale agreement that would see the Cambridgeshire-based firm offload its immuno-oncology assets to Portage Biotech.